Vertebral osteomyelitis

被引:12
作者
Jung, N. [1 ]
Seifert, H. [2 ]
Siewe, J. [3 ]
Faetkenheuer, G. [1 ]
机构
[1] Uniklin Koln, Innere Med Klin 1, D-50935 Cologne, Germany
[2] Uniklin Koln, Inst Med Mikrobiol Immunol & Hyg, D-50935 Cologne, Germany
[3] Uniklin Koln, Klin & Poliklin Orthopadie & Unfallchirurg, D-50935 Cologne, Germany
来源
INTERNIST | 2013年 / 54卷 / 08期
关键词
Hematogenous seeding; Pathogen identification; Staphylococcus aureus; Long-term antibiotic treatment; Interdisciplinary treatment; STAPHYLOCOCCUS-AUREUS; CLINICAL-FEATURES; EPIDEMIOLOGY;
D O I
10.1007/s00108-012-3142-2
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Infections of the vertebra and neighboring disc create the characteristic lesions of vertebral osteomyelitis. The incidence has been estimated to range from 0.3 to 6.5 cases/100,000 persons. The hematogenous route of infection is predominant while direct inoculation through iatrogenic procedures and contiguous spread from adjacent tissue are rare. Most patients with hematogenous vertebral osteomyelitis exhibit predisposing factors, such as advanced age and diabetes mellitus. Diagnosis is often delayed due to the nonspecific nature of back pain, the main symptom. Furthermore, fever is frequently absent. Staphylococcus aureus is the most prevalent pathogen of pyogenic vertebral osteomyelitis in Europe. Magnetic resonance imaging (MRI) is the method of choice for the radiological diagnosis and blood cultures belong to the standard procedures. In cases of negative blood cultures a biopsy is generally warranted for microbiological diagnosis, either by computed tomography (CT)-guided needle biopsy or open surgery. Randomized trials that have addressed different antibiotic regimens are lacking. The recommended duration of treatment ranges from 6 weeks to 3 months. Patients with abscesses and implant devices in particular should be treated for 3 months.
引用
收藏
页码:945 / +
页数:7
相关论文
共 31 条
[1]   The epidemiology of hematogenous vertebral osteomyelitis: a cohort study in a tertiary care hospital [J].
Bhavan, Kavita P. ;
Marschall, Jonas ;
Olsen, Margaret A. ;
Fraser, Victoria J. ;
Wright, Neill M. ;
Warren, David K. .
BMC INFECTIOUS DISEASES, 2010, 10
[2]  
Cornely OA, 2012, EMPFEHLUNGEN THERAPI, P26
[3]   A Seven-Year Prospective Study on Spondylodiscitis: Epidemiological and Microbiological Features [J].
D'Agostino, C. ;
Scorzolini, L. ;
Massetti, A. P. ;
Carnevalini, M. ;
d'Ettorre, G. ;
Venditti, M. ;
Vullo, V. ;
Orsi, G. B. .
INFECTION, 2010, 38 (02) :102-107
[4]   Comparative study of postoperative and spontaneous pyogenic spondylodiscitis [J].
Dufour, W ;
Feydy, A ;
Rillardon, L ;
Redondo, A ;
Le Page, L ;
Bert, F ;
Belmatoug, N ;
Fantin, B .
SEMINARS IN ARTHRITIS AND RHEUMATISM, 2005, 34 (05) :766-771
[5]  
Fantoni M, 2012, EUR REV MED PHARMACO, V16, P2
[6]   Usefulness of broad-range PCR for the diagnosis of osteoarticular infections [J].
Fenollar, Florence ;
Levy, Pierre-Yves ;
Raoult, Didier .
CURRENT OPINION IN RHEUMATOLOGY, 2008, 20 (04) :463-470
[7]   Spondylodiscitis: update on diagnosis and management [J].
Gouliouris, Theodore ;
Aliyu, Sani H. ;
Brown, Nicholas M. .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2010, 65 :iii11-iii24
[8]   Epidemiology of vertebral osteomyelitis (VO) in France: analysis of hospital-discharge data 2002-2003 [J].
Grammatico, L. ;
Baron, S. ;
Rusch, E. ;
Lepage, B. ;
Surer, N. ;
Desenclos, J. C. ;
Besnier, J. M. .
EPIDEMIOLOGY AND INFECTION, 2008, 136 (05) :653-660
[9]   Bacteremic Staphylococcus aureus spondylitis [J].
Jensen, AG ;
Espersen, F ;
Skinhoj, P ;
Frimodt-Moller, N .
ARCHIVES OF INTERNAL MEDICINE, 1998, 158 (05) :509-517
[10]  
Khan Mustafa H, 2006, Spine J, V6, P311, DOI 10.1016/j.spinee.2005.07.006